Clinical Significance of Measuring Soluble Urokinase-Type Plasminogen Activator Receptor in Cancerous Pleural Effusion

高维强,王兆钺,白霞,阮长耿
DOI: https://doi.org/10.3969/j.issn.1001-9057.2002.06.008
2002-01-01
Abstract:Objective To investigate the clinical significance of measuring soluble urokinase type plasminogen activator receptor (suPAR) in pleural effusion of cancer patients.Methods The suPAR levels in pleural effusion of 26 cancer patients and 10 inflammatory patients,and in plasma of 21 healthy individuals were measured by an immunoradiometric assay.Results The suPAR levels were(4.36±2.12)μg/L,(2.64±1.05)μg/L and(1.73±0.96)μg/L in cancerous pleural effusion,inflammatory pleural effusion and in normal plasma,respectively.The suPAR level in cancerous pleural effusion was higher than that of inflammatory pleural effusion,and the latter was also elevated in comparison with that of normal plasma. Moreover,the suPAR level was shown to be inversely associated with the survival time of cancer patients.Conclusion Detection of suPAR level is helpful for differentiating the benign and malignant pleural effusion, and for predicting the prognosis of cancer patients.
What problem does this paper attempt to address?